The PRODIGY Trial
PRODIGY (PRediction of Opioid‐induced respiratory Depression In patients monitored by capnoGraphY) is a prospective, multi‐center, international cohort study to assess the potential for respiratory compromise (RC) risk assessment in patients receiving opioids on the hospital general care floor also examining the value of continuous capnography and oximetry monitoring.
-
The PRODIGY Study at a Glance
-
Infographic: Learn About the PRODIGY Study
-
3:16
Video: PRODIGY Animation
-
Respiratory Compromise PRODIGY FAQ
-
Complimentary PRODIGY Risk Prediction Tool
-
55:27
Interviews on Respiratory Compromise
Thought leaders discuss why they believe respiratory compromise is an important safety issue needing better solutions.
-
2:28
Video: Evidence Summary of PRODIGY Study
-
PRODIGY Podcast
Dr. Ludwig Lin interviews Dr. Ashish Khanna on the PRODIGY study, awarded a Star Research Presentation at the SCCM conference.
-
Explore Remote Continuous Monitoring Solutions
Learn More -
White Paper: Who Are Your High Risk Respiratory Patients & How to Assess Them
-
2:25
Video: Evidence Summary PRODIGY Seeking Answers
-
CSM Khanna Seeking Answers from PRODIGY Clinical Summary
-
Cost efficiency and patient safety
-
BACK TO RESPIRATORY COMPROMISE RESOURCES
VIEW ALL -
Loading More...